HAEMANGIOBLASTOMA (contd) Clinical features
Cerebellar signs and symptoms or the effects of CSF obstruction usually develop insidiously. Occasionally subarachnoid haemorrhage occurs. In female patients, symptoms often appear during pregnancy. Polycythaemia due to increased erythropoietin production is common.
CT scan shows a well defined low density cyctic region in the cerebellum with a strongly enhancing nodule in the wall. Occasionally, multiple lesions are evident. MR I gives more anatomical detail (see pages 39-41).
nodule cyst nodule cyst
In most patients operative removal of the tumour nodule is straightforward, but recurrences (or further tumours at other sites, e.g. spine) develop in 20%.
Medulloblastomas occur predominantly in childhood, with a peak age incidence of about 5 years. They arise in the cerebellar vermis and usually extend into the 4th ventricle. All are highly malignant and spread readily throughout the CSF pathways, often seeding to the lateral ventricles or the spinal theca. The origin is uncertain but appears to arise from primitive embryonic cells.
Destruction of the cerebellar vermis causes truncal and gait ataxia often developing over a few weeks.
Alternatively, the patient presents with signs and symptoms of raised intracranial pressure due to blockage of CSF drainage. In the very young, failure to recognise these features has resulted in permanent visual loss from severe papilledema.
CT scan shows an isodense midline lesion in the cerebellar vermis, compressing and displacing the 4th ventricle and enhancing strongly with contrast.
Higher cuts shows dilated ventricles, sometimes containing CSF tumour seedlings.
318 MRl may provide more anatomical detail
Was this article helpful?
This guide will help millions of people understand this condition so that they can take control of their lives and make informed decisions. The ebook covers information on a vast number of different types of neuropathy. In addition, it will be a useful resource for their families, caregivers, and health care providers.